| 2 | The Use of Sentinel Lymph Node Biopsy in Patients Undergoing Mastectomy for DCIS. (Johnson MK, Cortina CS, Aldakkak M, Huang CC, Kong AL) Clin Breast Cancer 2024 Oct;24(7):611-619 |
| 1 | Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia. (Shanno JN, Daly AE, Anderman KJ, Santa Cruz HS, Webster AJ, Pride RM, Specht MC, Gadd MA, Oseni TO, Verdial FC, Ozmen T, Kwait R, Colwell AS, Smith BL) Ann Surg Oncol 2024 Aug;31(8):5148-5156 1 Citation |
| 2 | Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens. (Gellings JA, Cortina CS, Jorns JM, Johnson MK, Huang CC, Kong AL) Am J Surg 2023 Feb;225(2):304-308 |
| 3 | Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database. (Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC, Kong AL) Clin Breast Cancer 2022 Aug;22(6):547-552 1 Citation |
| 2 | Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. (Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA) Ann Diagn Pathol 2021 Jun;52:151725 3 Citations |
| 1 | Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward. (Czaja R, Wu R, Jorns JM) Arch Pathol Lab Med 2021 Aug 01;145(8):1018-1024 10 Citations |
| 1 | Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing. (Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ) Am J Pathol 2019 May;189(5):956-965 19 Citations |
| 1 | Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up. (Muller KE, Roberts E, Zhao L, Jorns JM) Arch Pathol Lab Med 2018 Mar;142(3):391-395 17 Citations |
| 1 | Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience. (Jorns JM, Daignault S, Sabel MS, Myers JL, Wu AJ) Eur J Surg Oncol 2017 Jul;43(7):1273-1281 14 Citations |
| 1 | Papillary Lesions of the Breast: A Practical Approach to Diagnosis. (Jorns JM) Arch Pathol Lab Med 2016 Oct;140(10):1052-9 22 Citations |
| 1 | Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision. (Walters LL, Pang JC, Zhao L, Jorns JM) Histopathology 2015 Mar;66(4):577-86 7 Citations |
| 1 | Vertebral sarcoidosis masquerading as breast metastasis. (Braza DW, Nelson PA) Am J Phys Med Rehabil 2014 Mar;93(3):274 5 Citations |
| 1 | The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer. (Hauser AD, Bergom C, Schuld NJ, Chen X, Lorimer EL, Huang J, Mackinnon AC, Williams CL) Mol Cancer Res 2014 Jan;12(1):130-42 24 Citations |
| 1 | Review of estrogen receptor, progesterone receptor, and HER-2/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution. (Jorns JM, Healy P, Zhao L) Arch Pathol Lab Med 2013 Nov;137(11):1660-3 14 Citations |
| 1 | Blogging through cancer: young women's persistent problems shared online. (Keim-Malpass J, Baernholdt M, Erickson JM, Ropka ME, Schroen AT, Steeves RH) Cancer Nurs 2013;36(2):163-72 57 Citations |
| 1 | Initiating breast cancer by PIK3CA mutation. (Miller TW) Breast Cancer Res 2012 Feb 07;14(1):301 17 Citations |
| 1 | Predicting cancer on excision of atypical ductal hyperplasia. (Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, Yao K) Am J Surg 2008 Mar;195(3):358-61; discussion 361-2 34 Citations |
| 1 | Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). (Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G, Kuerer HM) Breast J 2007;13(1):72-5 24 Citations |
| 1 | Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. (Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM) Cancer 2004 Mar 01;100(5):942-9 48 Citations |
| 1 | Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. (Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM) Am J Surg 2003 Oct;186(4):371-7 116 Citations |
| 1 | An axillary recurrence of breast cancer following a negative sentinel lymph node biopsy. (Yen TW, Mann GN, Lawton TJ, Livingston RB, Anderson BO) Breast J 2003;9(3):234-6 9 Citations |
© 2025 Clinical & Translational Science Institute